跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lotemax loteprednol etabonate 0.5% eye drop suspension - TGA Drug Approval Details
Approvals
/
TGA
/
Lotemax loteprednol etabonate 0.5% eye drop suspension
Approved
STANDARD
Lotemax loteprednol etabonate 0.5% eye drop suspension
Bausch & Lomb Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
c28c08f84ead5f42
Company
Bausch & Lomb Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
c28c08f84ead5f42
Product Name
Lotemax loteprednol etabonate 0.5% eye drop suspension
Artg Id
202525
Artg Name
Lotemax loteprednol etabonate 0.5% eye drop suspension
Sponsor
Bausch & Lomb Australia Pty Ltd
Company Detail Path
/organization/bausch-and-lomb-australia-pty-ltd
Artg Date
2014-01-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
c28c08f84ead5f42
Type
Standard
Back to TGA Approvals
